​

Nyxoah Stock (NASDAQ:NYXH)

ForecastRevenueFinancialsChartTranscripts
Nyxoah by TradingView

Previous Close

$5.98

52W Range

$5.55 - $12.21

50D Avg

$9.22

200D Avg

$8.88

Market Cap

$207.01M

Avg Vol (3M)

$117.69K

Beta

0.65

Div Yield

-

NYXH Company Profile

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

BE

Employees

183

IPO Date

Apr 28, 2021

Website

NYXH Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
Spain$72.00K$37.00K$24.00K
Switzerland$763.00K$373.00K$214.00K
AUSTRIA$60.00K$122.00K-
Germany$4.06M$3.82M$2.80M
ITALY$46.00K--

Fiscal year ends in Dec 23 | Currency in EUR

NYXH Financial Summary

Dec 23Dec 22Dec 21
Revenue$4.30M$3.08M$852.00K
Operating Income$4.30M$-32.50M$-26.24M
Net Income-$-31.23M$-27.62M
EBITDA-$-25.74M$-22.57M
Basic EPS-$-1.21$-1.16
Diluted EPS-$-1.21$-1.16

Fiscal year ends in Dec 23 | Currency in EUR

Latest Earnings Call Transcripts

Q4 24Mar 13, 25 | 8:00 AM
Q2 24Aug 11, 24 | 4:30 PM
Q4 23Mar 05, 24 | 4:30 PM

Peer Comparison

TickerCompany
NXGLNEXGEL, Inc.
PDEXPro-Dex, Inc.
LMATLeMaitre Vascular, Inc.
KRMDKORU Medical Systems, Inc.
MMSIMerit Medical Systems, Inc.
DXRDaxor Corporation
ATRCAtriCure, Inc.
ZJYLJin Medical International Ltd.
UTMDUtah Medical Products, Inc.